ArticleBMC medical imaging2024
Enhanced Cross-stage-attention U-Net for esophageal target volume segmentation.
Article in BMC medical imaging, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- A human-AI collaborative workflow for improved gross tumor volume delineation in esophageal cancer radiotherapy.BMC medical imaging · 2026Article
- Automated segmentation of esophageal squamous cell carcinoma in contrast-enhanced free-breathing 3D-GRE: a comparative study of UNet, nnUNet, and UMamba for tumor delineation.BMC medical imaging · 2025Article
- AI-Guided Delineation of Gross Tumor Volume for Body Tumors: A Systematic Review.Diagnostics (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
purposeThe segmentation of target volume and organs at risk (OAR) was a significant part of radiotherapy. Specifically, determining the location and scale of the esophagus in simulated computed tomography images was difficult and time-consuming primarily due to its complex structure and low contrast with the surrounding tissues. In this study, an Enhanced Cross-stage-attention U-Net was proposed to solve the segmentation problem for the esophageal gross tumor volume (GTV) and clinical tumor volume (CTV) in CT images.
methodsFirst, a module based on principal component analysis theory was constructed to pre-extract the features of the input image. Then, a cross-stage based feature fusion model was designed to replace the skip concatenation of original UNet, which was composed of Wide Range Attention unit, Small-kernel Local Attention unit, and Inverted Bottleneck unit. WRA was employed to capture global attention, whose large convolution kernel was further decomposed to simplify the calculation. SLA was used to complement the local attention to WRA. IBN was structed to fuse the extracted features, where a global frequency response layer was built to redistribute the frequency response of the fused feature maps.
resultsThe proposed method was compared with relevant published esophageal segmentation methods. The prediction of the proposed network was MSD = 2.83(1.62, 4.76)mm, HD = 11.79 ± 6.02 mm, DC = 72.45 ± 19.18% in GTV; MSD = 5.26(2.18, 8.82)mm, HD = 16.22 ± 10.01 mm, DC = 71.06 ± 17.72% in CTV.
conclusionThe reconstruction of the skip concatenation in UNet showed an improvement of performance for esophageal segmentation. The results showed the proposed network had better effect on esophageal GTV and CTV segmentation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.